Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor.

Should You Buy #1 (Strong Buy)-Ranked Adtalem Global Education (ATGE) for Your Portfolio?

Adtalem Global Education was upgraded to the Zacks Rank #1 list on February 14, 2025. The Zacks Rank is a unique stock-rating model that helps you take advantage of earnings estimate revision trends and provides a way to get into stocks highly sought after by institutional investors.

Adtalem Global Education Inc. is a leading healthcare education provider and workforce solutions innovator. The institutions of the company offer a wide array of programs across medical and healthcare services. Since first-quarter fiscal 2022, Adtalem has operated in three reportable segments:

Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2025. The Zacks Consensus Estimate has increased $0.31 to $6.20 per share. ATGE boasts an average earnings surprise of 21.6%.

Earnings are expected to grow 23.8% for the current fiscal year, while revenue is projected to increase 9.4%.

Additionally, ATGE has climbed higher over the past four weeks, gaining 5.4%. The S&P 500 is up 4.7% in comparison.

Bottom Line

With a #1 (Strong Buy) ranking, positive trend in earnings estimate revisions, and strong market momentum, Adtalem Global Education could be just the stock to help your portfolio generate returns that could fund your retirement, your kids' college tuition, or your short- and long-term savings goals.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Adtalem Global Education Inc. (ATGE) : Free Stock Analysis Report

Zacks Investment Research